Completed PHASE4 INTERVENTIONAL 2-arm NCT05348980

Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension

Comparison of Two Different Doses of Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension During Cesarean Section: A Prospective Randomized Double-blinded Parallel Study

Sponsor: Rehman Medical Institute - RMI

Conditions Anesthesia Hypotension

Interventions Phenylephrine Hydrochloride 4 mg Phenylephrine Hydrochloride 8 mg

Updated 3 times since 2022 Last updated: Apr 21, 2022 Started: Jan 1, 2020 Primary completion: Jul 31, 2020 Completion: Jul 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Anesthesia and Hypotension, this trial is completed. The trial is conducted by Rehman Medical Institute - RMI and has accumulated 3 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
May 2022 — Jul 2024 [monthly]

Completed PHASE4

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rehman Medical Institute - RMI

Data source: Rehman Medical Institute - RMI

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Peshawar, Pakistan